Back to search
Cerebral Adrenoleukodystrophy (cALD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cerebral Adrenoleukodystrophy (cALD) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cerebral Adrenoleukodystrophy (cALD) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy.
The main aim of this study is to assess and describe the safety outcomes, including newly diagnosed malignancies, of patients with CALD treated with eli-cel in…
This is a single-institution study to evaluate the use of intravenously administered allogeneic, 3rd party mesenchymal stem cells (IV-MSC) in patients with acti…
This is a Phase 1/2 randomized, blinded, dose-escalation study to evaluate the safety and efficacy of intrathecal (IT) administration of SBT101, a recombinant a…